Aileron Therapeutics (ALRN) Misses Q3 EPS by 27c
Tweet
Share
E-mailGet Alerts ALRN Hot Sheet
Join SI Premium – FREE
Aileron Therapeutics (NASDAQ: ALRN) reported Q3 EPS of ($0.27).
For earnings history and earnings-related data on Aileron Therapeutics (ALRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
- Micropolis Robotics displays autonomous robots at Dubai investment event
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
